drugset / Trial / NCT00666718

A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes Patients

NCT00666718

Phase 3 Completed 374 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is designed to look at if a basal bolus regimen of insulin lispro protamine suspension (ILPS) provides the same glycemic control as a basal bolus regimen of insulin glargine (when one basal bolus regimen is injected once daily together with insulin lispro injected 2-3 times daily).

Timeline

Start
2008-04
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Background Insulin Lispro Protein / enzyme biologic
Comparator insulin glargine Protein / enzyme biologic
Background Insulin Lispro Protein / enzyme biologic Subcutaneous